Actualités sur Health

The International Osteoporosis Foundation (IOF)

Love your Bones on World Osteoporosis Day

Nyon, Switzerland (ots) - Today, on World Osteoporosis Day (October 20), the International Osteoporosis Foundation (IOF) and its 200 member patient and medical societies are calling on the public and health professionals around the world to take action for bone health and osteoporosis prevention. The global campaign, launched in more than six languages, urges people of all ages to take three essential steps to set a ...

Abbott Laboratories

Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals

Abbott Park, Illinois (ots/PRNewswire) - - Two publicly traded companies will offer shareholders distinct opportunities given unique investment identities, business profiles and attributes - Builds on a decade of strategic and operational advancements Today Abbott announced that it plans to separate into two ...

Agendia B.V.

EORTC, BIG, and Agendia Announce Completion of Patient Recruitment for International MINDACT Study

BRUSSELS, IRVINE, California, and AMSTERDAM, October 18, 2011 (ots/PRNewswire) -- The EORTC, BIG, and Agendia, a commercial-stage molecular cancer diagnostics company, today announced the completion of patient registration for the EORTC 10041/BIG3-04 MINDACT (Microarray In Node negative and 1-3 positive lymph node Disease may Avoid Chemotherapy Trial) study. More than ...

Cryo-Save AG

GMP Certification Awarded to Cryo-Save Lab, India

Zutphen, The Netherlands (ots/PRNewswire) - Cryo-Save becomes the first stem cell bank operating in India to receive the WHO-GMP certification In a country where lack of stringent regulations has been causing the general public to view stem cell banking with a certain degree of trepidation, there is reason to cheer. Cryo-Save India, subsidiary of the leading Europe-based family stem cell banking company, has become the ...

LifeWatch AG

EANS-Adhoc: LifeWatch and Magnacare sign an agreement for the NiteWatch Home Sleep Testing service (with document)

http://resources.euroadhoc.com/us/SWWwwWGh issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...

The International Osteoporosis Foundation (IOF)

Three Steps to Unbreakable Bones on World Osteoporosis Day

Nyon, Switzerland (ots) - For this year's World Osteoporosis Day (October 20), the International Osteoporosis Foundation (IOF) is releasing a 24-page report promoting a three-step strategy for healthy bones and strong muscles. To view the Multimedia News Release (MNR), please click: http://multivu.prnewswire.com/mnr/prne/iof/52143/ Professor Heike Bischoff-Ferrari, director Centre on Aging and Mobility at the University ...

LifeWatch AG

EANS-Adhoc: LifeWatch confirms Medicare payment of USD 11.8 million (with document)

http://resources.euroadhoc.com/us/Nc2UWfH0 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: Open Market / ...

Actavis Inc.

'Youth in Europe' drug prevention programme sees youth drinking drop from 42% to 9% / Iceland and Actavis continue to support the fight against substance abuse

Pevion Biotech AG

Pevion's therapeutic Candida vaccine shows robust systemic and mucosal immunogenicity, while epidemiological survey confirms excellent market potential

Ittigen/Bern, Switzerland (ots) - Pevion Biotech AG today announced latest results from the ongoing clinical study of its therapeutic Candida vaccine PEV7, showing high levels of specific antibodies and a 100% mucosal immune response rate. The announcement further included the results of the largest, international ...

sanofi-aventis Group

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (Aubagio?(*)) Significantly Reduced Relapse Rate, Disability Progression and Disease Activity

Paris (ots/PRNewswire) - - Findings from Two-Year Pivotal Phase III TEMSO Trial Published today in The New England Journal of Medicine - Sanofi and its subsidiary Genzyme announced today the publication of the pivotal Phase III TEMSO study with investigational once-daily oral medication teriflunomide in The New ...

LifeWatch AG

EANS-Adhoc: LifeWatch announces agreement with Heritage Provider Network (with document)

http://resources.euroadhoc.com/us/QP5on9qJ issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: Open Market / ...

Agendia B.V.

Agendia Successfully Completes Bi-Annual FDA Inspection

Irvine, California and Amsterdam (ots/PRNewswire) - Agendia, an innovative molecular cancer diagnostics company, today announced that the company successfully completed a recent, routine inspection of its Irvine, California-based laboratories by the US Food and Drug Administration (FDA). Agendia received FDA 510(k) clearance for its MammaPrint(R) breast cancer recurrence test in early 2007. It remains the first and only ...

Serono Symposia

Serono Symposia International Foundation (SSIF) - Cognition Disorders in MS - Florence - 30 September, 1 October 2011

Florence, Italy (ots/PRNewswire) - Cognitive impairment in multiple sclerosis is expressed in the clinical course of the disease in 43-70% of cases. It affects 1/3rd of school-aged patients The leading international experts in the field of neurological research for multiple sclerosis gathered in Florence for the ...

International Society for Cellular Therapy

International Society for Cellular Therapy (ISCT) Leads Roundtable With Major US Payors, Healthcare Providers and Industry to Initiate a Collaboration to Address Cell Therapy Product Reimbursement

Vancouver (ots/PRNewswire) - The interest of many insured US citizens was represented by participation of payor organizations including Anthem Blue Cross Blue Shield, LifeTrac and OptumHealth. In keeping with its mission to drive the commercialization of cell therapy products and advance global patient access, ISCT ...

ForaCare Suisse AG

ForaCare Suisse AG launches Bluetooth enabled Single-Device Smart Diabetes, BP Monitors

St. Gallen, Switzerland (ots) - ForaCare Suisse AG located in St. Gallen, Switzerland announced today the launch of a Bluetooth enabled innovative, smart single-unit devices for combined blood glucose and blood pressure (BP) monitoring. One device, the Comfort Pro GD 40, is approved for use by medical professionals and the other, Duo Ultima D40b, is being made ...

Bayer HealthCare Pharmaceuticals

Results of a New Multi-national Survey, Endorsed by International Non-Governmental Organisations (NGOs)

London (ots/PRNewswire) - - Young People Report High Levels of Unprotected Sex and Barriers Affecting Their Right to Obtain Trustworthy Information About Sex and Contraception Key survey results - Since 2009 the number of people having sex without contraception with a new partner has increased by - 111% in France ...

Delcath Systems, Inc.

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress

New York and Stockholm (ots/PRNewswire) - March 2011 Data Confirm Strong Treatment Effect of Chemosaturation Delcath Systems announced today that James F. Pingpank, MD, FACS, Associate Professor of Surgery at the University of Pittsburgh School of Medicine, will present updated investigator results from the Phase 3 ...

Takeda Pharmaceutical Company Limited

Takeda Receives Positive CHMP Opinion in Europe for Edarbi(TM) (azilsartan medoxomil) for the Treatment of Essential Hypertension

London and Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited (Takeda) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for EdarbiTM (azilsartan medoxomil, development code: TAK-491), a new ...

Mundipharma International

Targin® Provides Patients With Cancer Pain Superior Bowel Function Without Compromising Analgesic Efficacy[1]

Cambridge, England (ots/PRNewswire) - New research demonstrates oxycodone/naloxone prolonged-release tablets superiority compared with oxycodone prolonged-release tablets[1] Treatment with Targin(R)(oxycodone/naloxone) prolonged-release tablets provides superior bowel function without compromising analgesic efficacy ...

sanofi-aventis Group

Sanofi Pasteur Donates Vaccine Strain Used for Polio Eradication to WHO

Lyon, France (ots/PRNewswire) - - Vaccine strain used in the production of oral polio vaccines against type 3 poliovirus - Sanofi Pasteur, the vaccines division of Sanofi , announced today it is donating to the World Health Organization (WHO) a vaccine strain used for polio eradication. The biological material given by Sanofi Pasteur is the original viral seed used to ...

Agendia B.V.

Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint®

Irvine, California and Amsterdam (ots/PRNewswire) - - Peer-Reviewed Article Notes That Multi-Gene Subtyping Profile Provides Deeper Insight Into Breast Cancer Agendia, an innovative molecular cancer diagnostics company, today announced that a published report highlighting the development and validation of its 80-gene BluePrint breast cancer profile was published online ...

LifeWatch AG

EANS-Adhoc: LifeWatch AG confirms an investigation at its US subsidiary by the "OIG" (with document)

http://resources.euroadhoc.com/us/0uYGlcN6 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...

LifeWatch AG

EANS-Adhoc: LifeWatch to announce results for the second quarter 2011 (with document)

http://resources.euroadhoc.com/us/1HCW6Rjz http://resources.euroadhoc.com/us/IBzY8Led issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 ...

LifeWatch AG

EANS-Adhoc: LifeWatch AG to report on - Second Quarter 2011 Results on August 23, 2011

issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: Open Market / XETRA: Frankfurt, free trade: Berlin, Main Standard: SIX Swiss Exchange language: English ...

Helsinn Healthcare SA

Palonosetron Better Prevents Nausea and Vomiting Linked to High Emetogenic Chemotherapy Lung Cancer Patients

Amsterdam, The Netherlands (ots) - New data presented at the 14th World Conference on Lung Cancer in Amsterdam, The Netherlands, show the efficacy of the 2nd generation 5-HT3 receptor antagonist alone and in combination with aprepitant New data on the 2nd generation 5-HT3 receptor antagonist palonosetron, in the ...

European Renal Association - European Dialysis and Transplant Association (ERA-EDTA)

ERA-EDTA congress 2011: Late Breaking Clinical Trials II / Lowering LDL cholesterol does not significantly slow down CKD progression

Prague (ots) - The SHARP-study has shown that lowering LDL cholesterol with ezetimibe/simvastatin leads to a significant reduction in major atherosclerotic events among CKD-patients. Whether it also has a favourable effect on renal disease progression was another of the issues addressed by the SHARP study [abstract ...

European Renal Association - European Dialysis and Transplant Association (ERA-EDTA)

ERA-EDTA congress 2011: Late Breaking Clinical Trials I / RAVE study: In ANCA-associated vasculitis rituximab is just as effective and safe as standard therapy

Prague, Czech Republic (ots) - The randomised, double-blind, placebo-controlled multi-centre study (abstract no. 2511) investigated the efficacy and safety of the monoclonal antibody rituximab (RTX) in 197 ANCA-associated vasculitis (AAV) patients. This study showed that in patients with severe AAV a single course ...

LifeWatch AG

EANS-Adhoc: LifeWatch AG / Disclosure of Equity Participations of more than 5% (with document)

issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: ...

LifeWatch AG

EANS-Adhoc: Annual General Meeting of LifeWatch AG

issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: Open Market / XETRA: Frankfurt, free trade: Berlin, Main Standard: SIX Swiss Exchange language: English Contact: Sensus Investor & Public Relations, Zurich: Tel +41 43 366 55 ...

LifeWatch AG

EANS-Adhoc: LifeWatch AG to announce results for the first quarter 2011 (with document)

Contact: Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG; Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | E-mail kobibe@lifewatch.com Sensus Investor & Public Relations, Zürich; Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch Branche: Healthcare Providers ISIN: ...